IN-DATE
075402: Medtronic RF Marinr MCXL 7F Steerable Ablation Catheter, 55-75cm
Sign in to add this product to your favorites!
| Price: | $299.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 2 eaches |
| Status: | expired |
Additional Details
RF Marinr
075402
- Steerable Ablation Catheter
- Electrode Spacing: 2/5/2mm
- Length: 110cm
Features
- Multi-Curve
- 4mm tip electrode
- Embedded thermocouple temperature sensor
AccessGUDID Info
- FDA Product Code: LPB
- FDA Product Code Name: Cardiac ablation percutaneous catheter
- GMDN Term Code: 61785
- GMDN Term Name: Cardiac radio-frequency ablation system catheter
- GMDN Term Description: A sterile, flexible, steerable catheter intended to be used as part of a radio-frequency cardiac ablation system to apply radio-frequency alternating current to ablate areas of the endocardium of a beating heart in the treatment of cardiac arrhythmias; it is typically also intended to transmit electrical pacing stimuli to, and electrical responses from, the heart for electrophysiological (EP) mapping. It is intended to be introduced into the heart via venous access (e.g., femoral vein) and may contain monopolar and/or bipolar ablation electrodes. This is a single-use device.
More on Ablation | RF
Radiofrequency (RF) Ablation is a widely used thermal ablation technique that destroys targeted tissue by delivering high-frequency alternating current through a catheter or probe. The electrical energy creates heat, leading to localized coagulative necrosis and cell death. In cardiology, RF ablation is a cornerstone treatment for arrhythmias like atrial fibrillation, while in oncology, it’s used to treat tumors in the liver, kidney, lung, and other organs. RF ablation is valued for its precision, proven track record, and ability to be performed in a minimally invasive setting, often under imaging guidance.
Manufacturer
Medtronic Cardiovascular Therapies offers a broad range of solutions for treating peripheral artery disease, aortic aneurysms, deep vein thrombosis, and other vascular conditions. Key technologies include the Endurant II and Endurant IIs stent graft systems for abdominal aortic aneurysms, the IN.PACT Admiral drug-coated balloon for femoropopliteal disease, and the Abre venous self-expanding stent system for iliofemoral venous outflow obstruction. With a commitment to advancing minimally invasive therapies, Medtronic’s vascular innovations help restore blood flow, reduce procedural risk, and improve quality of life for patients with complex vascular disease.
There is no valid manufacturer warranty on the products that Synergy Surgical sells. Any services provided by the original manufacturer of the products we sell are not available. However, eSutures offers a 100% money back guarantee (less shipping) on every item we sell within 30 days of purchase. For details, please see our Return Policy.
